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The optimal mode of delivery for a pregnant hemophilia carrier isstill a matter of debate. The aim of the study was to determinethe incidence of intracranial hemorrhage and other major bleeds
in neonates with moderate and severe hemophilia in relationship to
mode of delivery and known family history. A total of 926 neonates,
786 with severe and 140 with moderate hemophilia were included in
this PedNet multicenter study. Vaginal delivery was performed in
68.3% (n=633) and Cesarean section in 31.6% (n=293). Twenty
intracranial hemorrhages (2.2%) and 44 other major bleeds (4.8%)
occurred. Intracranial hemorrhages occurred in 2.4% of neonates fol-
lowing vaginal delivery compared to 1.7% after Cesarean section
(P=not significant); other major bleeds occurred in 4.2% born by vagi-
nal delivery and in 5.8% after Cesarean section (P=not significant).
Further analysis of subgroups (n=813) identified vaginal delivery with
instruments being a significant risk factor for both intracranial hemor-
rhages and major bleeds (Relative Risk: 4.78-7.39; P<0.01); no other sig-
nificant differences were found between vaginal delivery without
instruments, Cesarean section prior to and during labor. There was no
significant difference in frequency for intracranial hemorrhages and
major bleeds between a planned Cesarean section and a planned vagi-
nal delivery. Children with a family history of hemophilia (n=466)
were more likely to be born by Cesarean section (35.8% vs. 27.6%),
but no difference in the rate of intracranial hemorrhages or major
bleeds was found. In summary, vaginal delivery and Cesarean section
carry similar risks of intracranial hemorrhages and major bleeds. The
‘PedNet Registry’ is registered at clinicaltrials.gov identifier: 02979119.
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ABSTRACT
Introduction
The optimal mode of delivery for a known hemophilia carrier, i.e. either vaginal
delivery (VD) or Cesarean section (CS), is still a matter of debate. A carrier may
have an increased bleeding risk herself that might need to be taken into account in
the obstetric planning but, from the fetal point of view, the key question is how
the mode of delivery may impact on the risk of major bleeds, and in particular
intracranial hemorrhages (ICH). These life threatening bleeds can also impair the
outcome in survivors due to serious neurological sequelae.1,2 Moreover, the require-
ment for intensive replacement therapy has been identi-
fied as a risk factor for inhibitor development in patients
with hemophilia A.3
Several studies have been published with quite a uni-
form consensus that around 3-4% of boys with hemophil-
ia born in countries with a good standard of obstetric care
have had ICH diagnosed during the neonatal period.2,4-6 It
has also been shown that instrumental delivery using for-
ceps or vacuum extraction (VE) is a major risk factor for
intra- and extracranial bleeds in neonates with hemophil-
ia.5,7,8 However, figures for bleeds associated with uncom-
plicated VD and CS and, consequently, recommendations
on mode of delivery vary between publications and guide-
lines.7,9-11 It is undisputed that the risk of a neonatal bleed
in a child with hemophilia is considerably higher than that
expected in a non-hemophilia population, although few
figures are available. The largest series, among the few
studies published on mode of delivery in the normal pop-
ulation, suggests an incidence of ICH of 1 per 1,900 in
spontaneous VD, 1 per 2,750 in CS with no labor, 1 per
907 delivered by CS during labor, 1 per 860 deliveries with
VE, and 1 per 664 delivered with the use of forceps.12
Using these numbers as a reference, the risk for ICH in
hemophilia boys is 60 times higher compared to healthy
neonates born by VD. 
Knowledge of carrier status in a pregnant woman, or the
knowledge of confirmed hemophilia in the fetus follow-
ing prenatal diagnosis (PND), may impact on obstetric
care, especially when planning the mode of delivery. In
recent cohorts, around 50% of all cases of hemophilia are
sporadic, i.e. newly diagnosed boys without family histo-
ry of hemophilia or without any knowledge of carrier sta-
tus in the mother at birth.13 Many published studies on the
delivery of a hemophilia child have not been able to dis-
tinguish between sporadic cases and cases with a known
family history of hemophilia. Some studies include
neonates with mild hemophilia and, furthermore, it is not
always possible to distinguish between CS performed as a
result of the baby having hemophilia or for other reasons,
and this complicates comparisons between studies.
The PedNet Registry is a prospective, multicenter data-
base that includes all children born since 1st January 2000
diagnosed with hemophilia A (HA) or B (HB) of all sever-
ities and treated in the 31 participating hemophilia centers
in Europe, Canada and Israel.14 Baseline data regarding the
neonatal period are collected on mode of delivery, neona-
tal events, family history of hemophilia, and gestational
age. This longitudinal prospectively collected cohort study
makes it possible to address questions of interest on
obstetric and neonatal issues.
The aim of this paper was to study the frequency of
ICH and other major bleeds in neonates with hemophilia
and the association with mode of delivery to improve
counseling of pregnant carriers in the future.  Furthermore,
the results will be stratified according to the presence or
absence of a prior knowledge of hemophilia in the family.   
Methods
Study group
Data were retrieved from the ‘PedNet Registry’ which is owned
and administered by the ‘PedNet Haemophilia Research
Foundation’, consisting of 31 international hemophilia treatment
centers and registered at clinicaltrials.gov identifier: 02979119.  The
purpose of the registry is to promote and facilitate research and
healthcare development in children with hemophilia. The PedNet
Registry includes all consecutive patients diagnosed and treated in
each center born after 1st January 2000. The aim of the PedNet reg-
istry is to establish large well-documented birth cohorts of
patients with hemophilia enabling studies on side effects and out-
come of treatment. Patient data are collected from birth onwards
prospectively and consist of all data concerning treatment, side
effects and outcome of treatment. Information is collected on
mode of delivery and during the first 75 exposure days of treat-
ment with factor concentrate; all major bleeds including ICH are
registered with detailed information. Approval for data collection
was obtained from the institutional review boards of each of the
31 centers taking part in the study, and written informed consent
was obtained from the parents or guardians of all participants in
accordance with the Declaration of Helsinki. The data quality in
the PedNet Registry is monitored regularly and independent
audits are carried out in all participating centers.14
Study population
All children included in the Registry by 1st January 2015 with
severe (factor VIII/IX activity, < 0.01 IU/mL) or moderate (factor
VIII/IX activity, 0.01-0.05 IU/mL) HA and HB and with at least one
follow up covering the neonatal period after the initial baseline
report were enrolled. This resulted in 926 children born between
1st January 2000 and 1st January 2015 with data on mode of deliv-
ery and the neonatal period, defined as 28 days after birth.
Prematurity was defined as up to 36 weeks of gestational age.
Data collection
We uniformly collected data on the mode of delivery (including
vaginal, vaginal instrumental, CS), and major bleeds including ICH
in the neonatal period. Data were also recorded on whether an
affected newborn belonged to a family with a known history of
hemophilia or was a sporadic case. 
Statistical analysis 
The primary outcome was ICH and major bleeds, the latter
defined as a bleed requiring treatment with factor concentrate and
not resolving within 24 hours during the neonatal period. The
determinants of outcome were mode of delivery and family histo-
ry of hemophilia, either known or unknown.  Statistical compar-
isons between different groups were made using χ2 test or
Fisher´s exact test at a significance level of 0.05. In the comparison
of four subgroups on mode of delivery, an overall test was per-
formed to compare the frequencies between all groups simultane-
ously. If an overall test was significant, it was followed by pair-
wise comparisons between the groups. The results of the pairwise
comparisons were corrected for multiple testing by Bonferroni
correction. Statistical power was shown by the width and magni-
tude of the 95% Confidence Interval (95%CI) according to the
CONSORT guidelines. All analyses were performed using IBM
SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM
Corp., NY, USA,  or R: A language and environment for statistical
Computing, version 3.4.2. Vienna, Austria, R Foundation for
Statistical Computing.
Results
Cohort demography
A total of 926 patients were included, 140 with moder-
ate and 786 with severe hemophilia comprising those
with HA [n = 803 (86.7%)], and HB [n=123 (13.3%)].
MOD in the 926 patients was vaginal in 633 (68.4%) and
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CS in 293 (31.6%). Sixty-two (6.7%) of the included
patients were preterm. For more detailed information on
cohort demographics see Table 1.
Intracranial hemorrhages and major bleeds
Twenty ICH (2.2%) and 44 other major bleeds (4.8%)
were recorded in the 926 children. The majority of major
bleeds were soft tissue bleeds (n=14), followed by muscle
bleeds (n=7) and mucous membrane bleeds (n=3). One
patient each suffered from a shoulder bleed, subgaleal
bleed, scalp bleed, cephalohematoma, hematemesis, and a
hepatic bleed; in 14 patients the bleeds were not further
defined. No significant difference was observed in the fre-
quency of bleeds when comparing HA to HB or moderate
to severe hemophilia.
In the whole cohort, major bleeds occurred at a frequen-
cy of 4.3% (27 of 633) after all vaginal deliveries and 5.8%
(17 of 293) after CS (P=0.32). The frequencies of ICH after
all vaginal deliveries was 2.4% (15 of 633), compared to
1.7% after CS (5 of 293), with no significance (P=0.631).
Term and preterm neonates
Data on gestational age was available in 849 of 926
neonates. When comparing major bleeds in term and
preterm deliveries, major bleeds occurred in 5.2% (41 of
787) of term and in 6.4% (3 of 62) of preterm babies with
no significant statistical difference between the groups
(P=1.0). The frequency of ICH in the term delivery group
was 2.5% (20 of 787) and no cases of ICH was reported in
the preterm delivery group (n=62). In the preterm group,
neonates were born at a median of 35 gestational weeks
(range 26-36 weeks) and only 11 of 62 (17.7%) neonates
were very or extremely preterm (born before the 33rd ges-
tational week). Unfortunately, in 77 cases, gestation at
delivery was not recorded, but no major bleeds were
reported in this group (Table 2). Because there was no dif-
ference between the groups based on gestational age, all
further analysis was carried out on the whole cohort.
Mode of delivery
In 813 of 926 patients, more information about the
mode of delivery was available and further subgroups
could be defined: non-instrumental vaginal delivery
(n=541), vaginal with instruments, e.g. forceps or vacuum
extraction (n=68), CS prior to labor (n=125), and CS dur-
ing labor (n=79). The frequencies for ICH were 1.5% (8 of
541) for non-instrumental vaginal delivery, 10.2% (7 of 68)
for instrumental vaginal delivery, 1.6% (2 of 125) CS prior
labor, and 2.5% (2 of 79) during labor. Regarding major
bleeds, the frequencies showed 2.6% (14 of 541) for non-
instrumental vaginal delivery, 19.1% (13 of 68) for instru-
mental vaginal delivery, 4.0% (5 of 125) CS prior to labor,
and 8.9% (7 of 79) for CS during labor. The results identify
vaginal instrumental delivery as a significant risk factor in
comparison to vaginal delivery without instruments and
CS prior to labor for both major bleeds and ICH: the
Relative Risk (RR) for ICH was 6.96 (95%CI: 2.61-18.6;
P=0.0005) and the RR for major bleeds was 7.39 (95%CI:
3.63-15.05; P<0.0001) for comparison with vaginal deliv-
ery without instruments; compared to CS prior to labor
the RR was 6.43 (95%CI: 1.37-30.12; P=0.010) for ICH
and 4.78 (95%CI: 1.78-12.84; P=0.0012) for major bleeds.
Regarding major bleeds only at a significance level of
P<0.05, vaginal delivery without instruments was signifi-
cantly safer than CS during labor (P=0.011; RR 3.42,
95%CI: 1.43, 8.22) but no difference for ICH could be
seen (P=0.37). All other groups showed no significances in
comparison; there was no significant difference in the rate
of ICH or major bleeds when comparing instrumental
vaginal delivery with CS during labor. For more details see
Tables 3 and 4.
A subanalysis of moderate versus severe hemophilia was
made showing similar results regarding ICH: 2.14% (3 of
140) ICH for moderate and 2.16% (17 of 786) for severe
hemophilia without statistical significance. However,
major bleeds were significantly more often reported in
severe hemophilia 5.5% (43 of 786) than in moderate
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Table 1. Basic characteristics of study group. 
                                                                                        n ( %)
Type and severity of hemophilia
Moderate hemophilia A                                                         110 (11.9)
Severe hemophilia A                                                               693 (74.8)
Moderate hemophilia B                                                           30 (3.2)
Severe hemophilia  B                                                              93 (10.0)
Family history of hemophilia                                                             
No known family history                                                        445 (48.1)
Known family history                                                              466 (50.3)
No data on family history                                                         15 (1.6)
Mode of delivery                                                                                 
Vaginal delivery                                                                        633 (68.4)
Cesarean section                                                                    293 (31.6)
Gestational age                                                                                    
Born term                                                                                  787 (85.0)
Born preterm                                                                             62 (6.7)
No data term/preterm                                                             77 (8.3)
Total                                                                             926
Table 2. Major bleed and intracranial hemorrhage (ICH) in term or
preterm delivery in the first 28 days.
                                                   All      Major bleed n (%)          ICH n (%)
Term                                                   787                41 (5.2)                        20(2.5)
Preterm                                              62                   3 (6.4)                           0 (0)
Missing data term/preterm           77                    0 (0)                            0 (0)
Total                                                  926                      44                                  20
Table 3. Intracranial hemorrhage (ICH) and major bleeds and mode of
delivery.
                                                           All                ICH         Major bleeds
                                                            n                n (%)              n (%)
Vaginal delivery without                          541                8 (1.5)             14 (2.6)
instruments
Vaginal instrumental                                 68                7 (10.2)           13 (19.1)
Cesarean prior to labor                           125                2 (1.6)              5 (4.0)
Cesarean during labor                              79                  2 (2.5)              7 (8.9)
No detailed information on MOD         113                1 (0.8)              5 (4.4)
Total                                                             926                     20                      44
MOD: mode of delivery.
hemophilia 0.7% (1 of 140) (P=0.009) where only one
major bleed in the neonatal period was reported. 
The analysis of major bleeds in severe hemophilia only
showed the same significant results regarding vaginal
instrumental delivery as a risk factor compared to vaginal
delivery without instruments (P<0.0001; RR 7.28) and CS
prior to labor (P=0.0004; RR 6.05) (Table 3); therefore,
these groups were kept together in the further analysis.  
Family history of hemophilia
In 466 neonates there was a known family history of
hemophilia. In 445 cases, no family history of hemophilia
was known; these patients represent sporadic cases where
no influence on mode of delivery could be made. The rate
of CS differed significantly between the groups (P=0.009):
35.8% (167 of 466) in the group with known family histo-
ry were born by CS and 27.6% (123 of 445) of the spo-
radic cases (Table 5). The reason for planned CS in the
group of known family history was hemophilia carrier sta-
tus and/or known hemophilia status of the child in 45.2%
(38 of 84 cases), in 14.3% (12 of 84 cases) due to a combi-
nation of hemophilia status and maternal/fetal issues, and
in  29.8% not related to hemophilia (n=16 cases, maternal;
n=9 cases, fetal). The reasons recorded for a planned CS in
the group with no known family history of hemophilia
(n=49) were maternal reasons in 65.3% (n=32), fetal rea-
sons in 24.5% (n=12), combined reasons in 4.1% (n=2),
and Other in 6.1% (n=3). Vaginal instrumental deliveries
occurred less often when a family history was known (18
of 466) than in the group with no known family history
(48 of 445) (P=0.00038).
However, there was no significant difference in the fre-
quency of major bleeds and ICH between the group with
known family history (KFH) and the group with no
known family history (NFH) (P=0.87 and P=0.37, respec-
tively).  In the KFH group, we found an overall frequency
of 4.7% (22 of 466) for major bleeds and 1.7% (8 of 466)
for ICH. In comparison, in NFH the frequency was of
4.5% (20 of 445) for major bleeds and 2.7% (12 of 445) for
ICH. For more detailed information see Table 5.
Prenatal diagnosis
Prenatal diagnosis was performed in 13.7% (62 of 466)
of the children with a known family history of hemophil-
ia. In this group, the rate of CS was significantly higher (32
of 62; 51.6% vs. 135 of 404, 33.4%) than in the group with
known family history and no PND (P=0.0068). 
Mortality
One child with no known family history died after CS
in labor due to ICH in the neonatal period. The patient
was diagnosed with ICH at six days of age and the diag-
nosis of hemophilia A was made on the same day; this
child was included in the analysis.
No other deaths related to major bleeds or ICH were
reported.
Counseling of a pregnant carrier of hemophilia
In counseling a pregnant carrier, the decision to be taken
is between a planned CS (in most cases prior to labor)
compared to planned vaginal delivery which can result in
vaginal delivery with or without instruments or CS during
labor. Patients with planned vaginal delivery (n=703) had
a non-instrumental vaginal delivery in 77% (541 of 703),
an instrumental delivery in 9.7% (68 of 703), and a CS dur-
ing labor in 9.9% (70 of 703); in 24 patients it was
unknown if the vaginal delivery was with or without
instruments (3.4%). Patients with planned CS (n=134) had
a CS prior to labor in 93.2% (125 of 134)  and in 9 patients
the CS was performed in labor (6.8%) (Table 6). We com-
pared planned CS (n=134) to planned vaginal delivery
(n=703) for the whole cohort, and no significant difference
could be seen for both ICH (P=0.75) and major bleeds
(P=0.82). The frequencies for ICH were 1.5% (2 of 134)
for planned CS and 2.4% (17 of 703) for planned vaginal
delivery. Frequencies for major bleeds were 3.7% (5 of
134) for planned CS and 4.8% (34 of 703) for planned vagi-
nal delivery. (See Table 6 for an overview.) We also com-
pared the subgroup of patients with known family history
of hemophilia and compared the number of major bleeds
and ICH in planned CS (n=84) and planned vaginal deliv-
ery (n=327); even here, there was no significant difference
(P=0.777 for major bleeds, P=1 for ICH). 
Discussion
In this multicenter study, no statistical difference was
Mode of delivery and neonatal bleeds in hemophilia
haematologica | 2019; 104(10) 2103
Table 4. Pairwise comparisons between groups on mode of delivery.
Reference group                                             Comparison group                                        ICH                                                    Major bleeding
                                                                                                                                      P-value; RR                                                P-value; RR 
                                                                                                                                         (95%CI)                                   (95%CI)/severe hemophilia only
Vaginal delivery without instruments                 Vaginal instrumental                                      §*0.0005; 6.96                                           §*<0.0001; 7.39 (3.63,15.05)/ 
                                                                                                                                                                    (2.61,18.60)                                              §*<0.0001; 7.28 (3.60,14.72)
Vaginal delivery without instruments               Cesarian prior to labor                                      1.0000; 1.08                                                 0.3758; 1.55 (0.57,4.21)/ 
                                                                                                                                                                     (0.23,5.03)                                                    0.3408; 1.20 (0.4.;3.58)
Vaginal delivery without instruments                Cesarian during labor                                       0.3709; 1.71                                                 *0.0110; 3.42 (1.43,8.22)/ 
                                                                                                                                                                     (0.37,7.92)                                                 *0.0209; 3.20 (1.34; 7.66)
Cesarian prior to labor                                                       Vaginal                                                    *0.0100; 6.43                                              §*0.0012; 4.78(1.78,12.84)/
                                                                                             instrumental                                              (1.37,30.12)                                              §*0.0004; 6.05 (2.07, 17.72)
Cesarian during labor                                                         Vaginal                                                     0.0814; 4.07                                                  0.0918; 2.16 (0.91,5.10)/
                                                                                             instrumental                                              (0.87,18.92)                                                 0.1263; 2.27 (0.97, 5.32)
Cesarian prior to labor                                         Cesarian during labor                                       0.6417; 1.58                                                  0.2207; 2.22 (0.73,6.74)/
                                                                                                                                                                    (0.23,11.01)                                                0.09396; 2.66 (0.81, 8.76)
ICH: intracranial hemorrhage; RR. relative risk; CI: Confidence Interval. *Significant at significance level P<0.05; §significant after Bonferroni correction P<0.0083.
found in the rate of major bleeds and intracranial hemor-
rhage in neonates with moderate and severe hemophilia
between vaginal delivery and Cesarean section: major
bleeds occurred in 4.3% neonates born by VD and in
5.8% after CS (P=not significant, ns); ICH in 2.4% follow-
ing VD and 1.7% after CS (P=not significat, ns). Further
analysis of subgroups by MOD (VD with and without
instruments, CS prior to and during labor) revealed instru-
mental VD as a risk factor for major bleeds and intracra-
nial hemorrhage compared to non-instrumental VD (RR
7.39 major bleed; 6.96 ICH) and CS prior to labor.
Neonates with moderate hemophilia had a similar risk
regarding ICH compared to severe hemophilia, but a
lower risk for other major bleeds. No other significant dif-
ferences were found between the subgroups of vaginal
delivery without instruments, CS prior and CS during
labor. The CS rate was higher in neonates with a known
family history and reason was hemophilia  in more than
half of the cases. However, no significant difference was
found between the group with and without a known fam-
ily history of hemophilia regarding major bleeds and ICH.
The comparison of planned CS (including CS prior to
labor in 93.2% but also including some cases during labor)
to planned VD  (including VD without instruments in
77% and also instrumental VD and CS during labor) also
showed no significant difference in the group with known
family history
To our knowledge, this study represents the largest
prospective, monitored series recording comprehensive
data on mode of delivery and neonatal bleeds in patients
with moderate and severe hemophilia. The data come
from countries with a good and quite uniform standard of
health care which should make the results relevant and
applicable for these countries, although the results may
also be applicable to countries with different health care
standards. Due to the inclusion of all consecutive cases in
the participating centers, selection bias should be low but
cannot be totally excluded. Missing data is a problem for
most registries. Earlier publications of the PedNet registry
show high quality data regarding baseline data and first 75
exposure days including bleeds, with only 4% missing
data.14 The subanalysis on detailed information on mode
of delivery (vaginal with instruments, CS prior to or dur-
ing labor, reason for CS) was available in 813 of 926
(87.8%) patients, which means that in 12.2% of included
patients these data are missing, which is still acceptable
for analysis. However, the frequencies for both major
bleeds and ICH are low, and small differences between
the groups analyzed cannot be detected due to the limited
number of included patients. For example, to show a dif-
ference between ICH in vaginal delivery of 2.4% to CS of
1.7%, over 12,000 patients would have to be included,
which is not feasible. We excluded mild hemophilia from
our analysis since the diagnosis in these patients is often
made at an older age and undiagnosed cases born during
the study period have not yet been included in the PedNet
Registry.15
Both term and preterm neonates were included in the
calculations and one could question if data should have
been presented separately since ICH is a well-known
complication of, in particular, delivery of an extremely
premature neonate.16 Our series included 849 children
with data on gestational week of birth, of whom 62
(7.3%) were born prematurely, but only 11 children
(1.3%) were born before the 33rd gestational week, i.e.
very or extremely premature. There were three major
bleeds in the premature group (5.2%) and no cases of ICH.
In term births, 41 major bleeds in 787 neonates (6.4%)
occurred, and 20 ICH (20 of 787; 2.5%). Since there was
no significant difference in the frequency of bleeds
between the term and preterm groups we considered it
justified to merge them together in the calculations. The
premature group was still a rather small group, and a
much larger group would be needed in order to draw any
conclusions between the more extremely premature and
less premature on this issue. In another neonatal series,
N.G. Andersson et al.
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Table 5. Known and unknown family history of hemophilia.
                                                                           All                        Known family history                Unknown family history                          Family 
                                                                                                              of  hemophilia                             of hemophilia                              history not
                                                                                                                                                                                                                        known
                                                                             n                                     n (%)                                           n (%)                                             n
ICH                                                                                      20                                           8 (1.7)                                                 12 (2.7)                                                    0
Major bleeds                                                                    44                                          22 (4.7)                                                20 (4.5)                                                    2
Vaginal delivery                                                               633                                       299 (64.2)                                            322 (72.4)                                                 12
VD without instruments                                             541                                             285                                                        274                                                         5
VD instrumental                                                            68                                                14                                                          48                                                          6
Not known with/without instruments                       24                                                13                                                          10                                                          1
Cesarean section                                                           293                                      167 (35.8)*                                          123 (27.6)                                                  3
Planned CS                                                                    134                                              84                                                          49                                                          1
Reason:                                                                          
Hemophilia                                                                                                                    37                                                           -                                                          0
Combined hemophilia and maternal                                                                   12                                                           -                                                          0
or fetal status                                                                                                               
Maternal                                                                                                                      16                                                          32                                                          1
Fetal                                                                                                                              9                                                           12                                                          0
Combined maternal/fetal                                                                                         0                                                            2                                                           0
Other/unknown                                                                                                         9/1                                                         3/0                                                         0
Total number                                                                    926                                             466                                                        445                                                        15
*Significant at P<0.05 in comparison to unknown family history of hemophilia. n: number; ICH: intracranial hemorrhage; VD: vaginal delivery; CS: Cesarean section.
Richards et al.,8 with an overall head bleed rate of 3.5%
and some data on prematurity (29 premature children;
6.0% in the series), had the same issue. It is, however, pos-
sible that extreme prematurity is under-represented in the
registry due to mortality before diagnosis.
The frequency of major bleeds and ICH for all neonates
was similar to previous studies.9,17,18 When splitting the
group into instrumental VD and non-instrumental VD,
and CS prior to and during labor, only instrumental VD
was identified as a risk factor. A recent study from the UK
on ICH in bleeding disorders had similar findings and
identified instrumental delivery as a clear risk factor with
a RR of 10.6.19 This is also known from the normal popu-
lation, but in lower frequencies: Towner et al. reported
ICH frequencies of 1 of 860 for VE and 1 of 664 for forceps
and VE, which means that the risk for ICH in hemophilic
neonates born by instrumental delivery is roughly 80-fold
higher in our series.12 In a recent published meta-analysis
from Davies and Kadir, CS was proposed as a safer option
for children born with hemophilia, but the comparison
was made with historical cohorts.7 In our prospective
cohort, there was no difference in incidence of major
bleeds and ICH in neonates born by vaginal delivery (both
instrumental and non-instrumental) compared to CS (prior
to and during labor): 5.2% versus 6.4% in major bleeds,
and 2.3% versus 1.7% for ICH. A planned CS with the
intention to perform CS prior to labor did not prevent
neonates from experiencing ICH or major bleeds in com-
parison to planned VD. This information is important
when counseling a pregnant carrier. It has also been
shown in other studies that CS does not prevent neonatal
bleeds.4,8,9 Studies from the normal population with
583,340 births included show that vaginal delivery with-
out instruments and CS prior to labor were the safest
option but ICH still occurred (1 of 2,750 CS prior to labor,
and 1 of 1,900 delivered spontaneously).12
A known family history of hemophilia (KFH) had some
influence on the mode of delivery: 36% (167 of 466) were
delivered by CS in the KFH group compared to 28% (123
of 445) in the no known family history group (NFH)
(P=0.00038). The group of neonates in the NFH group
present the ‘true risk’ of neonatal bleeds in a child with
hemophilia, since no precautionary measures had been
taken with respect to hemophilia on the obstetric proce-
dures. However, there was no significant difference in the
rate of major bleeds and ICH between KFH and NFH.
Regarding vaginal delivery, 4.5% of the children in the
NFH group compared to 4.7% in the KFH had a major
bleed and 2.7% had ICH in the NFH-group compared to
1.7% in the KFH-group. This may be explained by our
findings, that the mode of delivery (CS vs. vaginal deliv-
ery) did not impact the rate of major bleeds and ICH.
Similar findings were shown in a recent study of Kulkarni
et al. in which 547 neonates with all severities of hemo-
philia were included.20 The reason to choose a planned CS
was hemophilia in 45%; but in 55%, other maternal and
fetal reasons played a role illustrating that the planning of
a delivery is a complicated and multifactorial task.
Prenatal diagnosis was performed in 14% (62 of 466) of
known carriers, and in these cases it was definitely known
that they were carrying a child with hemophilia. In this
subgroup, 51.6% were delivered by CS, demonstrating a
statistically significant impact on the decision to choose a
CS delivery. We do not have data on how many carriers
terminated pregnancy after PND with an affected fetus, so
the numbers on PND might be underestimated. However,
recent figures from Sweden indicate that carriers today
often choose PND in order to prepare for having a hemo-
philia child and not for termination of the pregnancy; but
this may not be the case in all participating centers.21
One child died from ICH, representing 1 of 786 boys
with severe hemophilia (0.13%), and 1 of 20 of all ICH
(5%). These numbers are low compared to historical data,
but they are in line with a recent CDC report that included
all ICH with a mortality rate of around 2.5%.22 These
numbers may be underestimated due to undiagnosed or
unreported cases. 
It would have been of interest to analyze the risks and
outcomes for the carrier mothers who gave birth to a child
with hemophilia according to delivery mode, but our reg-
istry is limited to pediatric data. 
In summary, vaginal delivery and Cesarean section carry
similar risks of ICH and major bleeds in neonates with
severe and moderate hemophilia, and pregnant carriers of
hemophilia should be informed about different options
for mode of delivery and their potential risks. 
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